Live
- BJP MP candidate Bharat Prasad visited the student who tried to commit suicide
- PM’s popularity in the fast lane: Autos with 'Har Dil Mein Modi' slogan spotted across Delhi
- Delhi-based political parties are like East India Company: Sukhbir Badal
- Golf: Diksha moves into Top-20 at South African Women’s Open
- KCR lashes out against BJP and Congress for destroying Telangana
- Dairy Science students visited the Milk cooling plant
- Moody feels Pant ahead in keepers’ race for T20 WC squad; Srikkanth picks Rahul over Samson as reserve keeper
- Thanking voters for extending 'unparalleled support' to NDA, PM Modi says second phase 'too good'
- Natural Relief for Menstrual Cramps: Beetroot Juice Recipe
- Asha Worker died in a road accident
Aurobindo gets FDA nod for acid reflux drug
Highlights
City-based Aurobindo Pharma on Thursday said it had received final approval from the US health regulator to manufacture and market Famotidine Tablets used for acid reflux treatment.
Hyderabad: City-based Aurobindo Pharma on Thursday said it had received final approval from the US health regulator to manufacture and market Famotidine Tablets used for acid reflux treatment.
"The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Famotidine Tablets," the company said in a statement. Approval has been granted for Famotidine Tablets of 20 mg and 40 mg strengths.
The approved ANDA (Abbreviated New Drug Application) is bioequivalent and therapeutically equivalent to the reference listed drug product Pepcid Tablets, 20 mg and 40 mg, of Valeant Pharmaceuticals International, Inc, it added. Famotidine Tablets is used for the short-term treatment of gastroesophageal reflux disease and active duodenal ulcer.
Quoting IMS data, Aurobindo Pharma said the approved product had an estimated market size of $29 million for the twelve months ending October 2015. This is the 54th ANDA to be approved out of Unit VII formulation facility in Hyderabad, India for manufacturing Oral Non-Antibiotic products, the company said.
Business Bureau
Next Story
ADVERTISEMENT
